Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus

Recruiting

Phase 2

GL0034Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus

Sponsor:

Sun Pharmaceutical Industries Limited

Code:

NCT07282743

Conditions

Type II Diabetes Mellitus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

GL0034 Dose Level 1

GL0034 Dose Level 2

GL0034 Dose Level 3

GL0034 Dose Level 4

GL0034 Dose Level 5

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-03-10. This information was provided to ClinicalTrials.gov by Sun Pharmaceutical Industries Limited on 2026-02-12.